Esperion Therapeutics | Despesas De Vendas E Administração



Selling And Administration Expenses Alterar Data
AbbVie USD 3.29B 562M 2025-03
Alnylam Pharmaceuticals USD 239.95M 55.39M 2025-03
Amarin USD 36.57M 397K 2025-03
Amgen USD 1.69B 191M 2025-03
Biogen USD 572.5M 104.8M 2025-03
BioMarin Pharmaceutical USD 206.12M 50.65M 2025-03
Cipla INR 12.33B 354.8M 2025-03
CSL USD 1.18B 201M 2024-12
Cytokinetics USD 57.37M 4.97M 2025-03
Daiichi Sankyo JPY 208.21B 22.58B 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
Geron USD 40.02M 3.35M 2025-03
Grifols EUR 269.48M 49.95M 2024-12
Halozyme Therapeutics USD 42.36M 113K 2025-03
Ionis Pharmaceuticals USD 76M 12.08M 2025-03
Merck USD 2.53B 319M 2025-03
Moderna USD 212M 139M 2025-03
Pfizer USD 3.01B 1.27B 2025-03
PTC Therapeutics USD 161.92M 77.24M 2025-03
Regeneron Pharmaceuticals USD 633M 159.2M 2025-03
Sanofi EUR 2.22B 980M 2025-03
Sarepta Therapeutics USD 133.63M 30.24M 2025-03
United Therapeutics USD 170.1M 7.6M 2025-03



Esperion Therapeutics Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.